Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,180.00
Bid: 12,178.00
Ask: 12,182.00
Change: 10.00 (0.08%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London pre-open: G7 warns of Brexit risks

Fri, 27th May 2016 07:29

(ShareCast News) - Stocks are set for a slightly lower open as traders tread cautiously ahead of a speech by Fed chair Janet Yellen towards the close of trading in London and ahead of the release of key economic indicators Stateside.The fact that investors are heading into a long weekend on both sides of the Pond, ahead of key risk events next week including the US jobs report for May and an OPEC summit is also expected to restrain activity today.With little doubt, all eyes are on Yellen´s speech at Harvard University, which is scheduled for 15:30BST; although the possibility exists that she will not make policy relevant remarks, even the risk that she might is enough to keep many traders on the sidelines.The Footsie is seen starting the day 3 points higher from Thursday closing mark of 6,265.65."At the moment, it is all about Miss Yellen and all focus will be on her as she takes to the stage later today. Many think that she will be very hawkish and possibly reverberate the same message as her fellow colleagues; that the US economy warrants another rate hike," said Naeem Aslam, chief market analyst at Think Forex UK."We don't think it's the right venue," said Michael Gapen, chief US economist at Barclays Investment Bank. "I would be surprised if she made comments."Any comments would come after a hawkish set of FOMC minutes last week and several Fed governors adding since then that two to three rate hikes were on the table in 2016, possibly including at the next meeting, on 14-15 June.Acting as a backdrop, following their meeting at Ise-Shima, in central Japan, G7 leaders warned of the damage that Brexit might inflict."A UK exit from the EU would reverse the trend towards greater global trade and investment, and the jobs they create, and is a further serious risk to growth," they said in an official statement.The main Asian stock gauges are broadly higher, with the Shanghai Stock Exchange´s Composite Index standing 0.22% higher at 2,828.57 as of 07:30 BST.To take note of, reports indicate that Japanese prime minister Shinzo Abe might announce a decision to postpone a planned increase in the country´s consumption tax in April 2017.Linked to the above, figures released overnight revealed that core consumer prices in the Tokyo area - a lead indicator for price pressures in the world´s third-largest economy - slipped to a -0.5% year-on-year clip in May (consensus: -0.4%).On the data front, the main releases on Friday will be a second reading on US first quarter GDP at 13:30 BST followed ninety minutes later by the University of Michigan´s consumer confidence survey results for the end of May.Finance post up for grabs at WolseleyWolseley said on Friday that Simon Nicholls will not take up his role as chief financial officer later this year, as announced back in January, without giving any reasons. The FTSE 100 building materials group said David Keltner, current CFO of US subsidiary Ferguson Enterprises, will be appointed interim group CFO on 1 September and the selection process to appoint a permanent CFO will commence immediately. The company confirmed Ian Meakins will retire on 31 August 2016, while John Martin will succeed him as CEO on the 1 September as expected.Phamaceuticals giant AstraZeneca announced positive results for its Faslodex drug for the treatment of metastatic breast cancer in post-menopausal women who have not had prior hormonal treatment for home-receptor-positive breast cancer. The company said on Friday that Faslodex met its primary endpoint of extended progression-free survival.In addition, AZN said the US Food & Drug Administration has issued a complete response letter on the new drug application made for sodium zirconium cyclosilicate, the investigational medicine being developed for the treatment of hyperkalaemia (high potassium level in the blood serum) by wholly-owned subsidiary ZS Pharma.
More News
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more
19 Feb 2024 08:03

AstraZeneca's Tagrisso gains FDA approval

(Sharecast News) - Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer.

Read more
19 Feb 2024 07:49

LONDON BRIEFING: MoneySupermarket credits Insurance for growth in 2023

(Alliance News) - Stocks in London are set to fall at Monday's open, as concerns over US inflation trends curb risk appetite, and damp hopes of interest rate cuts from the Federal Reserve.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.